ֱ

Clinical Challenges

ESMO: Metastatic Breast Cancer

European Society for Medical Oncology

More in ESMO: Metastatic Breast Cancer

Clinical Challenges: Test Your Knowledge on New Breast Cancer Treatments

A three-part quiz covering our series on advanced breast cancer

Nov 26, 2023
A blue and pink neon sign with the words QUIZ TIME
Clinical Challenges: Sequencing in Metastatic TNBC

It may only get more complicated as new options are approved

Nov 26, 2023
ESMO over a photo of IFEMA Madrid in Spain.
Clinical Challenges: Sequencing in Metastatic, HER2-Positive Breast Cancer

Data have narrowed first- and second-line choices, but decisions must be tailored to the patient

Nov 21, 2023
ESMO over a photo of IFEMA Madrid in Spain.
Clinical Challenges: Managing Toxicities of Newer Breast Cancer Therapies

Antibody-drug conjugates in particular may present clinicians with less familiar side effects

Nov 15, 2023
ESMO over a photo of IFEMA Madrid in Spain.
Clinical Challenges: Test Your Knowledge on Metastatic Breast Cancer

A three-question quiz on HER2-low disease, brain metastases, and progression on CDK4/6 inhibitors

Sep 30, 2022
A blue and pink neon sign with the words QUIZ TIME
Clinical Challenges: Options After CDK4/6 Inhibitors in Breast Cancer

Rapidly changing landscape has brought new targeted agents and made staying up-to-date vital

Sep 30, 2022
ESMO over a photo of Venue Porte de Versailles, Paris France
Clinical Challenges: The Low-Down on HER2-Low

The new category could encompass a majority of metastatic, unresectable breast cancers

Sep 09, 2022
ESMO over a photo of Venue Porte de Versailles, Paris France
Clinical Challenges: When to Start End-of-Life Care in Metastatic Breast Cancer

Some patients live years with advanced disease; when should end-of-life care talks happen?

Sep 30, 2021
ESMO over a computer rendering of a tumor.

1.00 CME Credits
Improving Transitions of Care and Long-Term Outcomes for Patients With Spinal Muscular Atrophy (SMA)

3.00 CME Credits
Pain Management and the 2022 CDC Guideline for Prescribing Opioids for Pain

1.00 CME Credits
Engaging Older Adults in Vaccine Education: A Toolkit for Healthcare Providers

1.00 CME Credits
Uncomplicated Urinary Tract Infections: Leveraging Real-World Insights to Improve Patient Care

0.25 CME Credits
Utilizing Biomarkers and Prognostic Factors to Identify Rheumatoid Arthritis Patients at Risk for Poor Outcomes

0.50 CME Credits
Enhancing Vaccine Uptake in Older Adults: Supporting Conversations With Your Patients

0.50 CME Credits
The Latest Evidence for Integrating Biomarkers and Prognostic Factors Into Treatment Plans for Patients With Rheumatoid Arthritis

0.25 CME Credits
Leveraging the Latest Data to Guide Precision Medicine in Rheumatoid Arthritis